Seguir
Daniel D Caspi
Daniel D Caspi
Consultant
Dirección de correo verificada de danielcaspi.com - Página principal
Título
Citado por
Citado por
Año
The total synthesis of (+)-dragmacidin F
NK Garg, DD Caspi, BM Stoltz
Journal of the American Chemical Society 126 (31), 9552-9553, 2004
2372004
Discovery of ABT-267, a pan-genotypic inhibitor of HCV NS5A
DA DeGoey, JT Randolph, D Liu, J Pratt, C Hutchins, P Donner, ...
Journal of medicinal chemistry 57 (5), 2047-2057, 2014
1462014
Development of an enantiodivergent strategy for the total synthesis of (+)-and (−)-dragmacidin F from a single enantiomer of quinic acid
NK Garg, DD Caspi, BM Stoltz
Journal of the American Chemical Society 127 (16), 5970-5978, 2005
1372005
Anti-viral compounds
DA Degoey, WM Kati, CW Hutchins, PL Donner, AC Krueger, ...
US Patent 8,691,938, 2014
1212014
The palladium‐catalyzed aerobic kinetic resolution of secondary alcohols: reaction development, scope, and applications
DC Ebner, JT Bagdanoff, EM Ferreira, RM McFadden, DD Caspi, ...
Chemistry–A European Journal 15 (47), 12978-12992, 2009
962009
The resolution of important pharmaceutical building blocks by palladium‐catalyzed aerobic oxidation of secondary alcohols
DD Caspi, DC Ebner, JT Bagdanoff, BM Stoltz
Advanced Synthesis & Catalysis 346 (2‐3), 185-189, 2004
722004
Kinetic Modeling of the Nickel-Catalyzed Esterification of Amides
NA Weires, DD Caspi, NK Garg
ACS Catalysis 7, 4381–4385, 2017
692017
Anti-Viral Compounds
DA Degoey, WM Kati, CW Hutchins, PL Donner, AC Krueger, ...
US Patent App. 12/903,822, 2011
612011
Process development of ABT-450–A first generation NS3/4A protease inhibitor for HCV
DD Caspi, RD Cink, D Clyne, M Diwan, KM Engstrom, T Grieme, J Mei, ...
Tetrahedron 75 (32), 4271-4286, 2019
182019
Heterogeneous Reductive Isomerization Reaction Using Catalytic Pd/C and H2
DD Caspi, NK Garg, BM Stoltz
Organic Letters 7 (12), 2513-2516, 2005
182005
The utility of the classical and oxidative Heck reactions in natural product synthesis: studies directed toward the total synthesis of dragmacidin F
NK Garg, DD Caspi, BM Stoltz
Synlett 2006 (18), 3081-3087, 2006
172006
Quantitative impurity rejection analysis for crystallization
DD Caspi, FL Nordstrom
Organic Process Research & Development 22 (7), 856-861, 2018
92018
Continuous multiphase flow nitration and cryogenic flow formylation: enabling process development and manufacturing of pharmaceutical intermediates
B Cardinal-David, KC Harper, A Verma, D Hanna, DD Caspi, C Vitale, ...
Organic Process Research & Development 25 (11), 2473-2481, 2021
62021
Anti-viral compounds
DA Degoey, WM Kati, CW Hutchins, PL Donner, AC Krueger, ...
62019
Rapid and Convergent Synthesis of a 2,4’-Linked Tri-oxazole in an Approach to Poly-oxazoles
DD Caspi, H Zhang, SC Virgil, FM Piller, BM Stoltz
Heterocycles 86 (2), 1003-1008, 2012
62012
Direct Preparation of Indole Hemiaminals through Organocatalytic Nucleophilic Addition of Indole to Aldehydes
N Zhang, Y Li, Z Chen, W Qin
Synthesis 50 (20), 4063-4070, 2018
42018
Anti-viral compounds
R Wagner, JK Pratt, D Liu, MD Tufano, DA Degoey, WM Kati, ...
US Patent 9,006,387, 2015
42015
Anti-viral compounds
DA Degoey, WM Kati, CW Hutchins, PL Donner, AC Krueger, ...
32012
Development of an Operational Space Using Mechanistic Models for a Pd-Catalyzed Amidation Reaction Used in the Synthesis of ABT-530
DD Caspi, M Diwan, JCC Califano, DJ Mack, S Shekhar
Organic Process Research & Development 23 (8), 1509-1521, 2019
22019
Potassium tert-Amylate: A Cautionary Tale
DD Caspi, SM Richter
The Journal of Organic Chemistry 84 (12), 8256-8258, 2019
22019
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20